The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
Open accessAbstract
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnosis can save lives. The USA-based National Lung Cancer Screening Trial reported a 20% relative reduction in lung cancer mortality and 6.7% all-cause mortality in low-dose computed tomography (LDCT)-screened subjects. Objectives: To (1) analyse LDCT lung cancer screening in a high-risk UK population, determine optimum recruitment, screening, reading and care pathway strategies; and (2) assess the psychological consequences and the health-economic implications of screening. Design: A pilot randomised controlled trial comparing intervention with usual care. A population-based risk questionnaire identified individuals who were at high risk of developing lung cancer (≥ 5% over 5 years). Setting: Thoracic centres with expertise in lung cancer imaging, respiratory medicine, pathology and surgery: Liverpool Heart & Chest Hospital, Merseyside, and Papworth Hospital, Cambridgeshire. Participants: Individuals aged 50–75 years, at high risk of lung cancer, in the primary care trusts adjacent to the centres. Interventions: A thoracic LDCT scan. Follow-up computed tomography (CT) scans as per protocol. Referral to multidisciplinary team clinics was determined by nodule size criteria. Main outcome measures: Population-based recruitment based on risk stratification; management of the trial through web-based database; optimal characteristics of CT scan readers (radiologists vs. radiographers); characterisation of CT-detected nodules utilising volumetric analysis; prevalence of lung cancer at baseline; sociodemographic factors affecting participation; psychosocial measures (cancer distress, anxiety, depression, decision satisfaction); and cost-effectiveness modelling. Results: A total of 247,354 individuals were approached to take part in the trial; 30.7% responded positively to the screening invitation. Recruitment of participants resulted in 2028 in the CT arm and 2027 in the control arm. A total of 1994 participants underwent CT scanning: 42 participants (2.1%) were diagnosed with lung cancer; 36 out of 42 (85.7%) of the screen-detected cancers were identified as stage 1 or 2, and 35 (83.3%) underwent surgical resection as their primary treatment. Lung cancer was more common in the lowest socioeconomic group. Short-term adverse psychosocial consequences were observed in participants who were randomised to the intervention arm and in those who had a major lung abnormality detected, but these differences were modest and temporary. Rollout of screening as a service or design of a full trial would need to address issues of outreach. The health-economic analysis suggests that the intervention could be cost-effective but this needs to be confirmed using data on actual lung cancer mortality. Conclusions: The UK Lung Cancer Screening (UKLS) pilot was successfully undertaken with 4055 randomised individuals. The data from the UKLS provide evidence that adds to existing data to suggest that lung cancer screening in the UK could potentially be implemented in the 60–75 years age group, selected via the Liverpool Lung Project risk model version 2 and using CT volumetry-based management protocols. Future work: The UKLS data will be pooled with the NELSON (Nederlands Leuvens Longkanker Screenings Onderzoek: Dutch–Belgian Randomised Lung Cancer Screening Trial) and other European Union trials in 2017 which will provide European mortality and cost-effectiveness data. For now, there is a clear need for mortality results from other trials and further research to identify optimal methods of implementation and delivery. Strategies for increasing uptake and providing support for underserved groups will be key to implementation. Trial registration: Current Controlled Trials ISRCTN78513845. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 40. See the NIHR Journals Library website for further project information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Modelling for Survival Data in Medical Research
(1995) · Technometrics · doi:10.1080/00401706.1995.10485920 · Cited by 2,145
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060476 · Cited by 1,706
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
Self-citationPostmus, P. E., Brambilla, E., Chansky, K., Crowley, J., Goldstraw, P., Patz, E. F., & Yokomise, H. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31811f4703 · Cited by 1,594
Raaschou-Nielsen, O., Andersen, Z. J., Beelen, R., Samoli, E., Stafoggia, M., Weinmayr, G., Hoffmann, B., Fischer, P., Nieuwenhuijsen, M. J., Brunekreef, B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70279-1 · Cited by 1,582
Probability of Cancer in Pulmonary Nodules Detected on First Screening CT
McWilliams, A., Tammemagi, M. C., Mayo, J. R., Roberts, H., Liu, G., Soghrati, K., Yasufuku, K., Martel, S., Laberge, F., Gingras, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214726 · Cited by 1,414
- Statistical Models for Epidemiology
(2013) · Bayesian Methods in Epidemiology · doi:10.1201/b15382-9 · Cited by 1,346
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Scott, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11522-4 · Cited by 1,262
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Callister, M. E. J., Baldwin, D. R., Akram, A. R., Barnard, S., Cane, P., Draffan, J., Franks, K., Gleeson, F., Graham, R., Malhotra, P., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207168 · Cited by 958
Self-citationMass screening for lung cancer with mobile spiral computed tomography scanner
Sone, S., Takashima, S., Li, F., Yang, Z., Honda, T., Maruyama, Y., Hasegawa, M., Yamanda, T., Kubo, K., Hanamura, K., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08229-9 · Cited by 931
Preventable Exposures Associated With Human Cancers
Cogliano, V. J., Baan, R., Straif, K., Grosse, Y., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr483 · Cited by 824
Management of Lung Nodules Detected by Volume CT Scanning
van Klaveren, R. J., Oudkerk, M., Prokop, M., Scholten, E. T., Nackaerts, K., Vernhout, R., van Iersel, C. A., van den Bergh, K. A. M., van 't Westeinde, S., van der Aalst, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906085 · Cited by 820
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Oken, M. M., Hocking, W. G., Kvale, P. A., Andriole, G. L., Buys, S. S., Church, T. R., Crawford, E. D., Fouad, M. N., Isaacs, C., Reding, D. J., et al. (2011) · JAMA · doi:10.1001/jama.2011.1591 · Cited by 655
Variations in Lung Cancer Risk Among Smokers
Bach, P. B., Kattan, M. W., Thornquist, M. D., Kris, M. G., Tate, R. C., Barnett, M. J., Hsieh, L. J., & Begg, C. B. (2003) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.470 · Cited by 642
Rami-Porta, R., Ball, D., Crowley, J., Giroux, D. J., Jett, J., Travis, W. D., Tsuboi, M., Vallières, E., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31807a2f81 · Cited by 637
CT Screening for Lung Cancer: Five-year Prospective Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Mandrekar, S. J., Hillman, S. L., Sykes, A.-M., Aughenbaugh, G. L., Bungum, A. O., & Allen, K. L. (2005) · Radiology · doi:10.1148/radiol.2351041662 · Cited by 636
Patient Satisfaction with Health Care Decisions: The Satisfaction with Decision Scale
Holmes-Rovner, M., Kroll, J., Schmitt, N., Rovner, D. R., Breer, M. L., Rothert, M. L., Padonu, G., & Talarczyk, G. (1996) · Medical Decision Making · doi:10.1177/0272989x9601600114 · Cited by 611
The English Indices of Deprivation 2010
McLennan, D., Barnes, H., Noble, M., Davies, J., Garrett, E., & Dibben, C. J. L. (2011) · Cited by 591
Small Pulmonary Nodules: Volumetrically Determined Growth Rates Based on CT Evaluation
Yankelevitz, D. F., Reeves, A. P., Kostis, W. J., Zhao, B., & Henschke, C. I. (2000) · Radiology · doi:10.1148/radiology.217.1.r00oc33251 · Cited by 579
Walters, S., Maringe, C., Coleman, M. P., Peake, M. D., Butler, J., Young, N., Bergström, S., Hanna, L., Jakobsen, E., Kölbeck, K., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202297 · Cited by 575
Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Computed Tomography Screening and Lung Cancer Outcomes
Bach, P. B. (2007) · JAMA · doi:10.1001/jama.297.9.953 · Cited by 567
Results of the Two Incidence Screenings in the National Lung Screening Trial
Aberle, D. R., DeMello, S., Berg, C. D., Black, W. C., Brewer, B., Church, T. R., Clingan, K. L., Duan, F., Fagerstrom, R. M., Gareen, I. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208962 · Cited by 550
Cost-Effectiveness of CT Screening in the National Lung Screening Trial
Black, W. C., Gareen, I. F., Soneji, S. S., Sicks, J. D., Keeler, E. B., Aberle, D. R., Naeim, A., Church, T. R., Silvestri, G. A., Gorelick, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312547 · Cited by 544
Guidelines on the radical management of patients with lung cancer
Lim, E., Baldwin, D., Beckles, M., Duffy, J., Entwisle, J., Faivre-Finn, C., Kerr, K., Macfie, A., McGuigan, J., Padley, S., et al. (2010) · Thorax · doi:10.1136/thx.2010.145938 · Cited by 539
Self-citationHumphrey, L. L., Deffebach, M., Pappas, M., Baumann, C., Artis, K., Mitchell, J. P., Zakher, B., Fu, R., & Slatore, C. G. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-6-201309170-00690 · Cited by 534
Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
Logan, R. F. A., Patnick, J., Nickerson, C., Coleman, L., Rutter, M. D., & von Wagner, C. (2012) · Gut · doi:10.1136/gutjnl-2011-300843 · Cited by 506
The LLP risk model: an individual risk prediction model for lung cancer
Cassidy, A., Myles, J. P., van Tongeren, M., Page, R. D., Liloglou, T., Duffy, S. W., & Field, J. K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604158 · Cited by 490
Self-citationde Koning, H. J., Meza, R., Plevritis, S. K., ten Haaf, K., Munshi, V. N., Jeon, J., Erdogan, S. A., Kong, C. Y., Han, S. S., van Rosmalen, J., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2316 · Cited by 466
Pastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., Pelosi, G., Boyle, P., & Fazio, F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14188-8 · Cited by 452
Statistical Issues in Drug Development
Senn, S. (2007) · doi:10.1002/9780470723586 · Cited by 448
Cullen, M. H., Billingham, L. J., Woodroffe, C. M., Chetiyawardana, A. D., Gower, N. H., Joshi, R., Ferry, D. R., Rudd, R. M., Spiro, S. G., Cook, J. E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3188 · Cited by 445
Pedersen, J. H., Ashraf, H., Dirksen, A., Bach, K., Hansen, H., Toennesen, P., Thorsen, H., Brodersen, J., Skov, B. G., Døssing, M., et al. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a0d98f · Cited by 434
Modelling Survival Data in Medical Research
(2004) · Technometrics · doi:10.1198/tech.2004.s817 · Cited by 430
Mammography Adherence and Psychological Distress Among Women at Risk for Breast Cancer
Lerman, C., Daly, M., Sands, C., Balshem, A., Lustbader, E., Heggan, T., Goldstein, L., James, J., & Engstrom, P. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.13.1074 · Cited by 427
Statistical Models in Epidemiology
Leger, A. S. S. (1994) · Journal of Epidemiology and Community Health · doi:10.1136/jech.48.6.607 · Cited by 425
A Risk Model for Prediction of Lung Cancer
Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., & Etzel, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk153 · Cited by 417
Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., Fabbri, A., Galeone, C., Negri, E., Sozzi, G., et al. (2012) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e328351e1b6 · Cited by 414
Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200736 · Cited by 390
Statistical Issues in Drug Development
Senn, S. (2021) · Wiley eBooks · doi:10.1002/9781119238614 · Cited by 384
IASLC肺癌病期分類プロジェクト:肺癌TNM分類次版(第7版)におけるT desriptor修正の提案
Rami–Porta, R., Ball, D., Crowley, J., Giroux, D., Jett, J. R., Wd, T., Tsuboi, M., Vallières, E., & Goldstraw, P. G. (2007) · Journal of Thoracic Oncology · Cited by 381
Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis
Brenner, D. R., McLaughlin, J. R., & Hung, R. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017479 · Cited by 343
von Wagner, C., Baio, G., Raine, R., Snowball, J., Morris, S., Atkin, W., Obichere, A., Handley, G., Logan, R. F., Rainbow, S., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr008 · Cited by 340
The psychological impact of mammographic screening. A systematic review
Brett, J., Bankhead, C., Henderson, B., Watson, E., & Austoker, J. (2005) · Psycho-Oncology · doi:10.1002/pon.904 · Cited by 327
Lopes Pegna, A., Picozzi, G., Mascalchi, M., Maria Carozzi, F., Carrozzi, L., Comin, C., Spinelli, C., Falaschi, F., Grazzini, M., Innocenti, F., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.07.003 · Cited by 294
Blanchon, T., Bréchot, J.-M., Grenier, P. A., Ferretti, G. R., Lemarié, E., Milleron, B., Chagué, D., Laurent, F., Martinet, Y., Beigelman-Aubry, C., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.05.009 · Cited by 271
Rubin, G. D., Lyo, J. K., Paik, D. S., Sherbondy, A. J., Chow, L. C., Leung, A. N., Mindelzun, R., Schraedley-Desmond, P. K., Zinck, S. E., Naidich, D. P., et al. (2005) · Radiology · doi:10.1148/radiol.2341040589 · Cited by 259
Villanti, A. C., Jiang, Y., Abrams, D. B., & Pyenson, B. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071379 · Cited by 243
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., & Murday, V (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690139 · Cited by 241
Cost-Effectiveness of Computed Tomography Screening for Lung Cancer in the United States
McMahon, P. M., Kong, C. Y., Bouzan, C., Weinstein, M. C., Cipriano, L. E., Tramontano, A. C., Johnson, B. E., Weeks, J. C., & Gazelle, G. S. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822e59b3 · Cited by 227
Baldwin, D. R., Duffy, S. W., Wald, N. J., Page, R., Hansell, D. M., & Field, J. K. (2011) · Thorax · doi:10.1136/thx.2010.152066 · Cited by 225
Self-citationBrenner, D. R., Boffetta, P., Duell, E. J., Bickeboller, H., Rosenberger, A., McCormack, V., Muscat, J. E., Yang, P., Wichmann, H. E., Brueske-Hohlfeld, I., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws151 · Cited by 216
Self-citationCoté, M. L., Liu, M., Bonassi, S., Neri, M., Schwartz, A. G., Christiani, D. C., Spitz, M. R., Muscat, J. E., Rennert, G., Aben, K. K., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.01.038 · Cited by 206
Self-citationHenschke, C. I., Yip, R., Yankelevitz, D. F., Smith, J. P., & for the International Early Lung Cancer Action Program Investigators* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00004 · Cited by 205
McCaffery, K., Waller, J., Forrest, S., Cadman, L., Szarewski, A., & Wardle, J. (2004) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00279.x · Cited by 203
2. Tobacco-attributable cancer burden in the UK in 2010
Parkin, D. M. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.475 · Cited by 198
van der Aalst, C. M., van den Bergh, K. A. M., Willemsen, M. C., de Koning, H. J., & van Klaveren, R. J. (2010) · Thorax · doi:10.1136/thx.2009.133751 · Cited by 189
Raji, O. Y., Duffy, S. W., Agbaje, O. F., Baker, S. G., Christiani, D. C., Cassidy, A., & Field, J. K. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-4-201208210-00004 · Cited by 181
Self-citationUK Association of Cancer Registries, Shack, L., Jordan, C., Thomson, C. S., Mak, V., & Møller, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-271 · Cited by 181
Earlier diagnosis and survival in lung cancer
Brett, G. Z. (1969) · BMJ · doi:10.1136/bmj.4.5678.260 · Cited by 177
Beliefs and attitudes about lung cancer screening among smokers
Jonnalagadda, S., Bergamo, C., Lin, J. J., Lurslurchachai, L., Diefenbach, M., Smith, C., Nelson, J. E., & Wisnivesky, J. P. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.05.095 · Cited by 175
Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts
Silvestri, G. A., Nietert, P. J., Zoller, J., Carter, C., & Bradford, D. (2007) · Thorax · doi:10.1136/thx.2005.056036 · Cited by 174
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
van den Bergh, K. A. M., Essink-Bot, M. L., Borsboom, G. J. J. M., Th Scholten, E., Prokop, M., de Koning, H. J., & van Klaveren, R. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605459 · Cited by 172
Psychosocial Influences on Older Adults' Interest in Participating in Bowel Cancer Screening
Wardle, J., Sutton, S., Williamson, S., Taylor, T., McCaffery, K., Cuzick, J., Hart, A., & Atkin, W. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0725 · Cited by 168
Espinosa de los Monteros, K., & Gallo, L. C. (2011) · International Journal of Behavioral Medicine · doi:10.1007/s12529-010-9119-4 · Cited by 168
An Expanded Risk Prediction Model for Lung Cancer
Spitz, M. R., Etzel, C. J., Dong, Q., Amos, C. I., Wei, Q., Wu, X., & Hong, W. K. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0060 · Cited by 160
Prospects for population screening and diagnosis of lung cancer
Field, J. K., Oudkerk, M., Pedersen, J. H., & Duffy, S. W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61614-1 · Cited by 155
Self-citationSmoking and drinking among adults, 2009
Robinson, S., Harris, H., & Dunstan, S. P. (2009) · Cited by 150
Ironmonger, L., Ohuma, E., Ormiston‐Smith, N., Gildea, C., Thomson, C. S., & Peake, M. D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.596 · Cited by 148
Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening
Byrne, M. M., Weissfeld, J., & Roberts, M. S. (2008) · Medical Decision Making · doi:10.1177/0272989x08322013 · Cited by 135
van den Bergh, K. A. M., Essink‐Bot, M., Borsboom, G. J. J. M., Scholten, E. T., van Klaveren, R. J., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00123410 · Cited by 133
McRonald, F. E., Yadegarfar, G., Baldwin, D., Devaraj, A., Brain, K. E., Eisen, T. G., Holemans, J. A., Ledson, M. J., Screaton, N. J., Rintoul, R. C., et al. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0206 · Cited by 127
Self-citationPyenson, B. S., Sander, M. S., Jiang, Y., Kahn, H., & Mulshine, J. L. (2012) · Health Affairs · doi:10.1377/hlthaff.2011.0814 · Cited by 125
Recent progress in computer-aided diagnosis of lung nodules on thin-section CT
Li, Q. (2007) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2007.02.005 · Cited by 123
Cipriano, L. E., Romanus, D., Earle, C. C., Neville, B. A., Halpern, E. F., Gazelle, G. S., & McMahon, P. M. (2011) · Value in Health · doi:10.1016/j.jval.2010.10.006 · Cited by 122
Wormanns, D., Ludwig, K., Beyer, F., Heindel, W. L., & Diederich, S. (2004) · European Radiology · doi:10.1007/s00330-004-2527-6 · Cited by 114
Miles, A., Rainbow, S. J., & von Wagner, C. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0453 · Cited by 105
European randomized lung cancer screening trials: Post NLST
Field, J. K., van Klaveren, R., Pedersen, J. H., Pastorino, U., Paci, E., Becker, N., Infante, M. V., Oudkerk, M., de Koning, H. J., & on behalf of the European Randomized Screening Trial Group (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23383 · Cited by 104
Self-citationThe impact of a lung cancer computed tomography screening result on smoking abstinence
van der Aalst, C. M., van Klaveren, R. J., van den Bergh, K. A. M., Willemsen, M. C., & de Koning, H. J. (2010) · European Respiratory Journal · doi:10.1183/09031936.00035410 · Cited by 103
Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study
McMahon, P. M., Kong, C. Y., Johnson, B. E., Weinstein, M. C., Weeks, J. C., Kuntz, K. M., Shepard, J.-A. O., Swensen, S. J., & Gazelle, G. S. (2008) · Radiology · doi:10.1148/radiol.2481071446 · Cited by 102
Taylor, K. L., Shelby, R. A., Gelmann, E. P., & McGuire, C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh194 · Cited by 100
Attitudes to participation in a lung cancer screening trial: a qualitative study
Patel, D., Akporobaro, A., Chinyanganya, N., Hackshaw, A. K., Seale, C. F., Spiro, S. G., & Griffiths, C. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200055 · Cited by 100
Kucharczyk, M. J., Menezes, R. J., McGregor, A., Paul, N. S., & Roberts, H. C. (2010) · Canadian Association of Radiologists Journal · doi:10.1016/j.carj.2010.02.008 · Cited by 99
Goo, J. M. (2011) · Korean Journal of Radiology · doi:10.3348/kjr.2011.12.2.145 · Cited by 86
Priola, A. M., Priola, S. M., Levra, M. G., Basso, E., Veltri, A., Fava, C., & Cardinale, L. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.05.005 · Cited by 85
Roos, J. E., Paik, D. S., Olsen, D., Liu, E. G., Chow, L. C., Leung, A. N. C., Mindelzun, R. E., Choudhury, K. R., Naidich, D. P., Napel, S. A., et al. (2009) · European Radiology · doi:10.1007/s00330-009-1596-y · Cited by 80
Iyen, B., Tata, L. J., Baldwin, D., Smith, C. J. P., & Hubbard, R. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202348 · Cited by 76
Self-citationBeigelman‐Aubry, C., Raffy, P., Yang, W., Castellino, R. A., & Greniér, P. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.07.2302 · Cited by 72
Comparison of discriminatory power and accuracy of three lung cancer risk models
D'amelio, A. M., Cassidy, A., Asomaning, K., Raji, O. Y., Duffy, S. W., Field, J. K., Spitz, M. R., Christiani, D. C., & Etzel, C. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605759 · Cited by 70
Self-citationEarly Detection of Lung Cancer
Pastorino, U. (2006) · Respiration · doi:10.1159/000090990 · Cited by 68
COPD as a disease of children: hype or hope for better understanding?
Mannino, D. M. (2009) · Thorax · doi:10.1136/thx.2009.118778 · Cited by 68
Marten, K., Seyfarth, T., Auer, F., Wiener, E., Grillh�sl, A., Obenauer, S., Rummeny, E., & Engelke, C. (2004) · European Radiology · doi:10.1007/s00330-004-2389-y · Cited by 64
Black, C., Bagust, A., Boland, A., Walker, S., McLeod, C., de Verteuil, R., Ayres, J. G., Bain, L., Thomas, S., Godden, D., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10030 · Cited by 61
Inoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine.
Provencio, M., Isla, D., Sánchez, A., & Cantos, B. (2011) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2011.01.02 · Cited by 59
van den Bergh, K. A. M., Essink‐Bot, M., van Klaveren, R. J., & de Koning, H. J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00098908 · Cited by 57
Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial
Aggestrup, L. M., Hestbech, M. S., Siersma, V., Pedersen, J. H., & Brodersen, J. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000663 · Cited by 54
Sojourn time and lead time projection in lung cancer screening
Wu, D., Erwin, D., & Rosner, G. L. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.010 · Cited by 47
Lung cancer screening by spiral CT. What is the optimal target population for screening trials?
van Klaveren, R. J., de Koning, H. J., Mulshine, J. L., & Hirsch, F. R. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00222-2 · Cited by 41
Trends in cancer incidence by deprivation, England and Wales, 1990-2002.
Rowan, S. (2007) · PubMed · Cited by 34
Adopting helical CT screening for lung cancer: Potential health consequences during a 15‐year period
McMahon, P. M., Kong, C. Y., Weinstein, M. C., Tramontano, A. C., Cipriano, L. E., Johnson, B. E., Weeks, J. C., & Gazelle, G. S. (2008) · Cancer · doi:10.1002/cncr.23962 · Cited by 31
Measurement Methods and Algorithms for the Management of Solid Nodules
Nair, A., Baldwin, D., Field, J. K., Hansell, D. M., & Devaraj, A. (2012) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e31824f83e1 · Cited by 29
Self-citationHenschke, C. I., Yankelevitz, D. F., & Kostis, W. J. (2003) · Seminars in Ultrasound CT and MRI · doi:10.1016/s0887-2171(03)90022-9 · Cited by 25
de Haan, M. C., Thomeer, M., Stoker, J., Dekker, E., Kuipers, E. J., & van Ballegooijen, M. (2012) · European Radiology · doi:10.1007/s00330-012-2689-6 · Cited by 19
Brain, K. E., Parsons, E. P., Bennett, P. D., Cannings-John, R. L., & Hood, K. (2010) · Psycho-Oncology · doi:10.1002/pon.1807 · Cited by 12
Self-citation
Cited by
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Jonas, D. E., Reuland, D. S., Reddy, S. M., Nagle, M., Clark, S. D., Weber, R. P., Enyioha, C., Malo, T. L., Brenner, A. T., Armstrong, C., et al. (2021) · JAMA · doi:10.1001/jama.2021.0377 · Cited by 633
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology
Wood, D. E., Kazerooni, E. A., Baum, S. L., Eapen, G. A., Ettinger, D. S., Hou, L., Jackman, D. M., Klippenstein, D., Kumar, R., Lackner, R. P., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0020 · Cited by 611
European position statement on lung cancer screening
Oudkerk, M., Devaraj, A., Vliegenthart, R., Henzler, T., Prosch, H., Heussel, C. P., Bastarrika, G., Sverzellati, N., Mascalchi, M., Delorme, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30861-6 · Cited by 587
Self-citation
Metadata
- Authors
- Field, J. K., Duffy, S. W., Baldwin, D. R., Brain, K. E., Devaraj, A., Eisen, T., Green, B. A., Holemans, J. A., Kavanagh, T., Kerr, K. M., Ledson, M., Lifford, K. J., McRonald, F. E., Nair, A., Page, R. D., Parmar, M. K., Rintoul, R. C., Screaton, N., Wald, N. J., Weller, D., Whynes, D. K., Williamson, P. R., Yadegarfar, G., & Hansell, D. M.
- Venue
- Health Technology Assessment
- Published
- 2016-05
- Volume
- 20
- Issue
- 40
- Pages
- 1-146
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2399706916
- Cited by
- 296
- References
- 111
- FWCI
- 17.74
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.